Small leucine rich repeat proteoglycans (SLRPs) in the human sclera: Identification of abundant levels of PRELP

Molecular Vision

Volumn 12, Issue , 2006, Pages 1057-1066

  Johnson, Janell Mae ^a   Young, Terri Lynn ^b   Summers Rada, Jody A ^c  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BIGLYCAN; CHONDROADHERIN; CORE PROTEIN; DECORIN; FIBROMODULIN; GLYCOPROTEIN; KERATAN SULFATE; LEUCINE; LUMICAN; MESSENGER RNA; PROLINE; PROTEOGLYCAN; RNA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ANALYSIS OF VARIANCE; ARTICLE; BIOMECHANICS; CHILD; CONTROLLED STUDY; DONOR; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SCLERA DISEASE; STEADY STATE; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LEUCINE; MALE; MIDDLE AGED; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCLERA; STAINING AND LABELING;

EID: 33748746585     PISSN: 10900535     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bloom W Fawcett DW, editors. A Textbook of Histology. New York: Chapman & Hall; 1994. p 875.
2. Rada JA, Achen VR, Perry CA, Fox PW. Proteoglycans in the human sclera. Evidence for the presence of aggrecan. Invest Ophthalmol Vis Sci 1997; 38:1740-51.
3. Hocking AM, Shinomura T, McQuillan DJ. Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 1998; 17:1-19.
4. Vogel KG, Paulsson M, Heinegard D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 1984; 223:587-97.
5. Hedbom E, Heinegard D. Binding of fibromodulin and decorin to separate sites on fibrillar collagens. J Biol Chem 1993; 268:27307-12.
6. Rada JA, Comuet PK, Hassell JR. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. Exp Eye Res 1993; 56:635-48.
7. Schonherr E, Witsch-Prehm P, Harrach B, Robenek H, Rauterberg J, Kresse H. Interaction of biglycan with type I collagen. J Biol Chem 1995; 270:2776-83.
8. Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Lozzo RV. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997; 136:729-43.
9. Svensson L, Aszodi A, Reinholt FP, Fassler R, Heinegard D, Oldberg A. Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem 1999; 274:9636-47.
10. Liu CY, Birk DE, Hassell JR, Kane B, Kao WW. Keratocan-deficient mice display alterations in corneal structure. J Biol Chem 2003; 278:21672-7.
11. Austin BA, Coulon C, Liu CY, Kao WW, Rada JA. Altered collagen fibril formation in the sclera of lumican-deficient mice. Invest Ophthalmol Vis Sci 2002; 43:1695-701.
12. Pellegata NS, Dieguez-Lucena JL, Joensuu T, Lau S, Montgomery KT, Krahe R, Kivela T, Kucherlapati R, Forsius H, de la Chapelle A. Mutations in KERA, encoding keratocan, cause comea plana. Nat Genet 2000; 25:91-5.
13. Lehmann OJ, El-ashry MF, Ebenezer ND, Ocaka L, Francis PJ, Wilkie SE, Patel RJ, Ficker L, Jordan T, Khaw PT, Bhattacharya SS. A novel keratocan mutation causing autosornal recessive comea plana. Invest Ophthalmol Vis Sci 2001; 42:3118-22.
14. Young TL, Guo XD, King RA, Johnson JM, Rada JA. Identification of genes expressed in a human scleral cDNA library. Mol Vis 2003; 9:508-14.
15. Young TL, Scavello GS, Paluru PC, Choi JD, Rappaport EF, Rada JA. Microarray analysis of gene expression in human donor sclera. Mol Vis 2004; 10:163-76.
16. Snead MP, Yates JR. Clinical and Molecular genetics of Stickler syndrome. J Med Genet 1999; 36:353-9.
17. Pousi B, Hautala T, Heikkinen J, Pajunen L, Kivirikko KI, Myllyla R. Alu-Alu recombination results in a duplication of seven exons in the lysyl hydroxylase gene in a patient with the type VI variant of Ehlers-Danlos syndrome. Am J Hum Genet 1994; 55:899-906.
18. Evereklioglu C, Madenci E, Bayazit YA, Yilmaz K, Balat A, Bekir NA. Central corneal thickness is lower in osteogenesis imperfecta and negatively correlates with the presence of blue sclera. Ophthalmic Physiol Opt 2002; 22:511-5.
19. Lewis M. PRELP, collagen, and a theory of Hutchinson-Gilford progeria. Ageing Res Rev 2003; 2:95-105.
20. Rada JA, Achen VR, Penugonda S, Schmidt RW, Mount BA. Proteoglycan composition in the human sclera during growth and aging. Invest Ophthalmol Vis Sci 2000; 41:1639-48.
21. Roughley PJ, White RJ, Magny MC, Liu J, Pearce RH, Mort JS. Non-proteoglycan forms of biglycan increase with age in human articular cartilage. Biochem J 1993; 295:421-6.
22. Grover J, Chen XN, Korenberg JR, Recklies AD, Roughley PJ. The gene organization, chromosome location, and expression of a 55-kDa matrix protein (PRELP) of human articular cartilage. Genomics 1996; 38:109-17.
23. Tarentino AL, Gomez CM, Plummer TH Jr. Deglycosylation of asparagine-linked glycans by peptide: N-glycosidase R Biochemistry 1985; 24:4665-71.
24. Ameye L, Young MF, Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 2002; 12:107R-16R.
25. Bengtsson E, Neame PJ, Heinegard D, Sommarin Y. The primary structure of a basic leucine-rich repeat protein, PRELP, found in connective tissues. J Biol Chem 1995; 270:25639-44.
26. Melching LI, Roughley PJ. A matrix protein of Mr 55,000 that accumulates in human articular cartilage with age. Biochim Biophys Acta 1990; 1036:213-20.
27. Bengtsson E, Aspberg A, Heinegard D, Sommarin Y, Spillmann D. The amino-terminal part of PRELP binds to heparin and heparan sulfate. J Biol Chem 2000; 275:40695-702.
28. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, Lose EJ. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 1992; 8:365-93.
29. Noonan DM, Fulle A, Valente P, Cai S, Horigan E, Sasaki M, Yamada Y, Hassell JR. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J Biol Chem 1991; 266:22939-47.
30. Tsen G, Halfter W, Kroger S, Cole GJ. Agrin is a heparan sulfate proteoglyean. J Biol Chem 1995; 270:3392-9.
31. Bengtsson E, Morgelin M, Sasaki T, Timpl R, Heinegard D, Aspberg A. The leucine-ricb repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor. J Biol Chem 2002; 277:15061-8.
32. Hassell JR, Schrecengost PK, Rada JA, SundarRaj N, Sossi G, Thoft RA. Biosynthesis of stromal matrix proteoglycans and basement membrane components by human corneal fibroblasts. Invest Oplithalmol Vis Sci 1992; 33:547-57.
33. Walls GL. The vertebrate eye and its adaptive radiation. Bulletin no. 19. Bloomfield Hills (MI): Cranbrook institute of science; 1942. p. 594-595, 643,678.
34. Panjwani N, Mohan R. The Sclera. In: Krachmer JH, Mannis MJ, Holland EJ, Krachmer P, editors. Comea. 1st ed. St. Louis: Mosby; 1997. p.30.
35. Curtin BJ. The myopias: basic science and clinical management. Philadelphia: Harper & Row; 1985.
36. Zhang Q, Guo X, Xiao X, Jia X, Li S, Hejtmancik JF. Novel locus for X linked recessive high myopia maps to Xq23-q25 but outside MYP1. J Med Genet 2006; 43:e2O.
37. Young TL, Atwood LD, Ronan SM, Dewan AT, Alvear AB, Peterson J, Holleschau A, King RA. Further refinement of the MYP2 locus for autosomal dominant high myopia by linkage disequilibrium analysis. Ophthalmic Genet 2001; 22:69-75.
38. Young TL, Ronan SM, Alvear AB, Wildenberg SC, Oetting WS, Atwood LD, Wilkin DJ, King RA. A second locus for familial high myopia maps to chromosome l2q. Am J Hum Genet 1998; 63:1419-24.
39. Naiglin L, Gazagne C, Dallongeville F, Tbalamas C, Idder A. Rascol O, Malecaze F, Calvas P. A genome wide scan for familial high myopia suggests a novel locus on chromosome 7q36. J Med Genet 2002; 39:118-24.
40. Paluru P, Ronan SM, Heon E, Devoto M, Wildenberg SC, Scavello G, Holleschau A, Makitie O, Cole WG, King RA, Young TL. New locus for autosomal dominant high myopia maps to the long arm of chromosome 17. Invest Ophthalmol. Vis Sci 2003; 44:1830-6.
41. Stambolian D, Tbay G, Reider L, Dana D, Moy C, Schlifka.M, Holmes T, Ciner E, Bailey-Wilson JE. Genomewide linkage scan for myopia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 22q12. Am J Hum Genet 2004; 75:448-59.
42. Hammond CJ, Andrew T, Mak YT, Spector TD. A susceptibility locus for myopia in the normal population is linked to the PAX6 gene region on chromosome 11: a genomewide scan of dizygotic twins. Am J Hum Genet 2004; 75:294-304.